Irvine, CA, United States of America

Richard Chamberlin


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Richard Chamberlin: Innovator in Cancer Treatment

Introduction

Richard Chamberlin is a notable inventor based in Irvine, California, recognized for his contributions to cancer treatment through innovative research. He has developed a patent that focuses on APE/REF1 inhibitors, which play a crucial role in the treatment of cancer.

Latest Patents

Chamberlin holds a patent for APE/REF1 inhibitors for the treatment of cancer. This patent details the use of Apurinic/apyrimidinic endonuclease 1/Redox Factor-1 (APE/Ref-1) inhibitors, along with methods for their application. The structure of the inhibitor is defined by Formula I, where 'n' is an integer ranging from 4 to 14, and both 'X' and 'X'' can be either H or OH. Additionally, 'Y' and 'Y′' are also independently H or OH, providing a versatile approach to cancer treatment.

Career Highlights

Throughout his career, Richard Chamberlin has worked with prestigious institutions such as Chapman University and the University of California. His work has significantly impacted the field of cancer research, showcasing his dedication to advancing medical science.

Collaborations

Chamberlin has collaborated with notable colleagues, including Sun Yang and Keykavous Parang, further enhancing the scope and impact of his research.

Conclusion

Richard Chamberlin's innovative work in developing APE/REF1 inhibitors marks a significant advancement in cancer treatment. His contributions reflect a commitment to improving healthcare through scientific research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…